NCT07298161 Evaluating SleepWhale Drops for Rest & Resilience
| NCT ID | NCT07298161 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Efforia, Inc |
| Condition | Sleep |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2026-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-08-25 with a primary completion date of 2026-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.
Eligibility Criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Allergies to supplement ingredients * Individuals on sleep Medication * Individuals with Gastrointestinal Issues * Individuals with Skin Conditions * Individuals Prone to Headaches * Individuals with Mental Health Conditions * Pregnant or Breastfeeding Individuals * Athletes and Competitive Participants * Individuals with Dependency Issues * Individuals with Dizziness or Fatigue Issues
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07298161 clinical trial?
This trial is open to participants of all sexes, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07298161 currently recruiting?
Yes, NCT07298161 is actively recruiting participants. Contact the research team at help@efforia.com for enrollment information.
Where is the NCT07298161 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07298161 clinical trial?
NCT07298161 is sponsored by Efforia, Inc. The trial plans to enroll 100 participants.